David Lawrence
Impact in
- Physiology top 1%
- Smoking Behavior and Cessation
- Asthma and respiratory diseases
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pulmonary Hypertension Research and Treatments
- Respiratory Support and Mechanisms
- Respiratory and Cough-Related Research
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 18
- Inhalation and Respiratory Drug Delivery 3
- Pulmonary Hypertension Research and Treatments 3
- Physiology 26
- Smoking Behavior and Cessation 14
- Asthma and respiratory diseases 12
- Co-authors
- Robert M. Anthenelli (12 shared papers)Neal L. Benowitz (8 shared papers)Thomas McRae (9 shared papers)Robert West (8 shared papers)A. Eden Evins (8 shared papers)Cristina Russ (8 shared papers)Alok Krishen (6 shared papers)John A. Ascher (1 shared paper)
- Journals
- Respiratory Medicine (9 papers)Annals of Oncology (4 papers)Pulmonary Pharmacology & Therapeutics (3 papers)Managerial and Decision Economics (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
David Lawrence
85 papers receiving 3.5k citations
David Lawrence's Hit Papers
Peers
Comparison fields: 5 of 161
- Physiology 1.3k
- Pulmonary and Respiratory Medicine 1.3k
- Family Practice 58
- Applied Psychology 89
- Cardiology and Cardiovascular Medicine 331
Countries citing papers authored by David Lawrence
This map shows the geographic impact of David Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lawrence more than expected).
Fields of papers citing papers by David Lawrence
This network shows the impact of papers produced by David Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lawrence. The network helps show where David Lawrence may publish in the future.
Co-authors
The 25 scholars most cited alongside David Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial Hit paper breakdown → | 2016 | 652 |
| 2 | Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension Hit paper breakdown → | 2013 | 419 |
| 3 | Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer Hit paper breakdown → | 2017 | 249 |
| 4 | 2013 | 195 | |
| 5 | 2010 | 157 | |
| 6 | Inclisiran and cardiovascular events: a patient-level analysis of phase III trials Hit paper breakdown → | 2022 | 138 |
| 7 | 2005 | 124 | |
| 8 | 2011 | 113 | |
| 9 | 2015 | 102 | |
| 10 | 2018 | 93 | |
| 11 | 2006 | 88 | |
| 12 | 2010 | 81 | |
| 13 | 1999 | 81 | |
| 14 | 2010 | 80 | |
| 15 | 2005 | 78 | |
| 16 | 2020 | 75 | |
| 17 | 2003 | 63 | |
| 18 | 2019 | 59 | |
| 19 | 2018 | 57 | |
| 20 | 2007 | 53 |
About David Lawrence
David Lawrence is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Oncology, Economics and Econometrics and Finance, having authored 89 papers that have together received 3.6k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Smoking Behavior and Cessation (14 papers), Asthma and respiratory diseases (12 papers), Cancer Immunotherapy and Biomarkers (4 papers), Banking stability, regulation, efficiency (3 papers), Inhalation and Respiratory Drug Delivery (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Forecasting Techniques and Applications (3 papers). The work is most often cited by research in Physiology (1.3k citations), Pulmonary and Respiratory Medicine (1.3k citations), Family Practice (58 citations), Applied Psychology (89 citations) and Cardiology and Cardiovascular Medicine (331 citations). David Lawrence has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Robert M. Anthenelli, Neal L. Benowitz, Thomas McRae, Robert West, A. Eden Evins, Cristina Russ, Alok Krishen, John A. Ascher, J. Taylor Hays and Benjamin Krämer. Their work appears in journals such as Respiratory Medicine, Annals of Oncology, Pulmonary Pharmacology & Therapeutics, Managerial and Decision Economics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.